Status:
TERMINATED
The Renin-Angiotensin System in Essential Hypertension
Lead Sponsor:
St George's, University of London
Conditions:
Hypertension
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Although ACE Inhibitors and Angiotensin Receptor Blockers are effective blood pressure lowering agents, the exact mechanisms by which these agents lower BP are still not fully understood. This study a...
Eligibility Criteria
Inclusion
- Essential Hypertension
- SBP 140-159 mmHg
- DBP 90-99 mmHg
Exclusion
- Intolerance of or allergy to ACE Inhibitors or ARBS
- Pregnant or Breastfeeding
- Pre-menopausal women
- Uncontrolled cardiac or renal failure
- Diabetes mellitus
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2006
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT00141583
Start Date
April 1 2004
End Date
October 1 2006
Last Update
June 9 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Blood Pressure Unit, Dept. Cardiac & Vascular Sciences, SGUL
London, United Kingdom, SW17 0RE